Neuromagen Pharma
Neuromagen Pharma develops drugs for neurodegenerative diseases including ALS.
Neuromagen Pharma is a business in biopharma, biotechnology, neuroscience based in Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA), founded in 2021.
Neuromagen Pharma is positioned in biopharma, biotechnology, neuroscience, a segment that rewards a clear, focused offering.
The business is associated with Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA).
Its current recorded stage is Private company.
Recorded headcount: c_00001_00010 employees.
| Sector | Biopharma, Biotechnology, Neuroscience |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA) |
| Founded | 2021 |
| Employees | c_00001_00010 |
| Stage | Private company |
Website: www.neuromagen.com
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account